Article ; Online: LUMiC® endoprosthesis for pelvic reconstruction: A Canadian experience.
2022 Volume 127, Issue 4, Page(s) 727–733
Abstract: Background and objectives: The LUMiC® prosthesis was introduced to reduce the mechanical complications encountered with periacetabular reconstruction after pelvic tumor resection. Few have evaluated the outcomes associated with its use.: Methods: A ... ...
Abstract | Background and objectives: The LUMiC® prosthesis was introduced to reduce the mechanical complications encountered with periacetabular reconstruction after pelvic tumor resection. Few have evaluated the outcomes associated with its use. Methods: A retrospective study from five Orthopedic Oncology Canadian centers was conducted. All patients with a LUMiC® endoprosthesis were included. Their charts were reviewed for surgical and functional outcomes. Results: A total of 16 patients were followed for 28 months (3-60). A total of 12 patients (75%) had a LUMiC® after a resection of a primary sarcoma. Mean surgical time was 555 min. Four patients (25%) had a two-stages procedure. MSTS score was 60.3 preoperatively and 54.3 postoperatively. Patients got a dual mobility bearing and the silver coated implant was used in 7 patients (43.7%). Five patients (31.3%) underwent capsular reconstruction using a fabric. Silver-coating was not found to reduce infection risk (p = 0.61) and capsuloplasty did not prevent dislocation (p = 0.6). Five patients had peroperative complications (31.3%). Eight patients (50%) had an infection including all four with two-stages surgery. Dislocation occurred in five patients (31.3%) whereas no cases of aseptic loosening were reported. A total of 10 patients (62.5%) needed a reoperation. Conclusion: LUMiC® endoprosthesis provides low rates of aseptic loosening on medium-term follow-up. Infection and dislocation are common complications but we were unable to show benefits of capsuloplasty and silver-coated implants. |
---|---|
MeSH term(s) | Humans ; Retrospective Studies ; Silver ; Bone Neoplasms/surgery ; Bone Neoplasms/pathology ; Canada ; Artificial Limbs ; Reoperation ; Treatment Outcome ; Prosthesis Failure ; Prosthesis Design |
Chemical Substances | Silver (3M4G523W1G) |
Language | English |
Publishing date | 2022-12-22 |
Publishing country | United States |
Document type | Journal Article |
ZDB-ID | 82063-5 |
ISSN | 1096-9098 ; 0022-4790 |
ISSN (online) | 1096-9098 |
ISSN | 0022-4790 |
DOI | 10.1002/jso.27181 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 706: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.